Comment
Potential for bias in economic analyses
- PMID: 1922247
Item in Clipboard
Comment
Potential for bias in economic analyses
N Engl J Med.
.
No abstract available
Comment on
-
Avoiding bias in the conduct and reporting of cost-effectiveness research sponsored by pharmaceutical companies.N Engl J Med. 1991 May 9;324(19):1362-5. doi: 10.1056/NEJM199105093241911. N Engl J Med. 1991. PMID: 1901959 No abstract available.
Similar articles
-
The benefits and threats of research partnerships with industry.Crit Care. 2005 Aug;9(4):309-10. doi: 10.1186/cc3539. Epub 2005 Apr 26. Crit Care. 2005. PMID: 16137365 Free PMC article. No abstract available.
-
Small study on industry trial sponsorship leads to big questions about quality and bias.J Natl Cancer Inst. 2007 Jul 4;99(13):988-90. doi: 10.1093/jnci/djm057. Epub 2007 Jun 27. J Natl Cancer Inst. 2007. PMID: 17596566 No abstract available.
-
[Researchers' statements concerning their economic liaisons].Lakartidningen. 2002 May 8;99(19):2191. Lakartidningen. 2002. PMID: 12082940 Swedish. No abstract available.
-
Research dishonesty and conflict of interest.N Z Med J. 2002 Dec 13;115(1167):U270. N Z Med J. 2002. PMID: 12552259 No abstract available.
-
[Independent clinical trials are imperative].Ugeskr Laeger. 2005 Apr 4;167(14):1491-4. Ugeskr Laeger. 2005. PMID: 15887740 Review. Danish. No abstract available.
Cited by
-
The Australian Guidelines for subsidisation of pharmaceuticals.Pharmacoeconomics. 1992 Nov;2(5):422-6. doi: 10.2165/00019053-199202050-00010. Pharmacoeconomics. 1992. PMID: 10147055 No abstract available.
-
Economic analysis as an aid to subsidisation decisions: the development of Australian guidelines for pharmaceuticals.Pharmacoeconomics. 1992 Jan;1(1):54-67. doi: 10.2165/00019053-199201010-00010. Pharmacoeconomics. 1992. PMID: 10147039
Publication types
MeSH terms
LinkOut - more resources
Full Text Sources